» Articles » PMID: 23797890

Probiotic Lactobacillus Casei Zhang Ameliorates High-fructose-induced Impaired Glucose Tolerance in Hyperinsulinemia Rats

Overview
Journal Eur J Nutr
Date 2013 Jun 26
PMID 23797890
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate the preventive and therapeutic effects of Lactobacilluscasei Zhang on impaired glucose tolerance (IGT) by using fructose-induced hyperinsulinemia rats.

Methods: Rats were fed 25 % fructose solution for hyperinsulinemia with L.casei Zhang for prevention or therapy. Serum levels of insulin, glucagon-like peptide-2 (GLP-2), osteocalcin, malondialdehyde (MDA), total intestinal bile acids and hepatic glycogen contents were determined by assay kits. The major bacteria from feces and liver expression of adiponectin receptor 2 (AdipoR2), liver X receptor-α (LXR-α), peroxisome proliferator-activated receptor gamma (PPAR-γ) and vitamin K epoxide reductase complex subunit 1 mRNA were assessed by RT-PCR. Pancreas injury was evaluated by histological analysis.

Results: Lactobacilluscasei Zhang significantly increased numbers of Lactobacillus and Bifidobacterium and decreased Clostridium in the intestine (p < 0.01). Meanwhile, liver glycogen contents were significantly decreased (p < 0.05). In preventive group, accompanied by significantly lower insulin and GLP-2 levels (p < 0.05), L.casei Zhang prevented rats from an increase in oral glucose tolerance area under curve (AUC) which was significant in hyperinsulinemia group (p < 0.05). In therapeutic group, L.casei Zhang administration possessed improved glucose tolerance (p < 0.05), which were associated with increased osteocalcin level (p < 0.01), improved intestinal bile acids secretion (p = 0.060), decreased serum MDA levels (p < 0.05) and upregulation of LXR-α, PPAR-γ and AdipoR2 gene expression, as well as an increase in Bacteroides fragilis (p < 0.05).

Conclusions: Lactobacilluscasei Zhang administration exert both preventive and ameliorative effect on oral glucose tolerance AUC in IGT rats but may be via different mechanisms. L.casei Zhang could prevent rats from increased AUC through GLP-2 lowering, while the ameliorative effect in high-fructose-fed post-adolescent rats may be via B. fragilis enriched vitamin K2-dependent osteocalcin mechanism in which AdipoR2, LXR-α and PPAR-γ signaling were involved.

Citing Articles

Refined highland barley ameliorates obesity-associated insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and liver transcriptomics.

Wu T, Dai Z, Luo Y, Yu Q, Zhang Y, Bao X Eur J Nutr. 2025; 64(2):96.

PMID: 39964534 DOI: 10.1007/s00394-025-03614-z.


Effects of live and pasteurized forms of Lactobacillus casei Zhang on acute kidney injury and chronic renal fibrosis.

Wang X, Shi M, Cao C, Zeng R, Yao Y Braz J Microbiol. 2024; 55(4):3699-3709.

PMID: 39222221 PMC: 11712044. DOI: 10.1007/s42770-024-01491-y.


The Anti-Inflammatory and Curative Exponent of Probiotics: A Comprehensive and Authentic Ingredient for the Sustained Functioning of Major Human Organs.

Virk M, Virk M, He Y, Tufail T, Gul M, Qayum A Nutrients. 2024; 16(4).

PMID: 38398870 PMC: 10893534. DOI: 10.3390/nu16040546.


Fructose: a modulator of intestinal barrier function and hepatic health?.

Staltner R, Burger K, Baumann A, Bergheim I Eur J Nutr. 2023; 62(8):3113-3124.

PMID: 37596353 PMC: 10611622. DOI: 10.1007/s00394-023-03232-7.


Screening for potential novel probiotic RAMULAB52 with antihyperglycemic property from fermented L.

Sreepathi N, Kumari V, Huligere S, Al-Odayni A, Lasehinde V, Jayanthi M Front Microbiol. 2023; 14:1168102.

PMID: 37408641 PMC: 10318367. DOI: 10.3389/fmicb.2023.1168102.


References
1.
Fukumoto S, Martin T . Bone as an endocrine organ. Trends Endocrinol Metab. 2009; 20(5):230-6. DOI: 10.1016/j.tem.2009.02.001. View

2.
Mathers J, Fernandez F, Hill M, McCarthy P, Shearer M, Oxley A . Dietary modification of potential vitamin K supply from enteric bacterial menaquinones in rats. Br J Nutr. 1990; 63(3):639-52. DOI: 10.1079/bjn19900150. View

3.
Takebayashi K, Aso Y, Inukai T . Role of bile acid sequestrants in the treatment of type 2 diabetes. World J Diabetes. 2011; 1(5):146-52. PMC: 3083899. DOI: 10.4239/wjd.v1.i5.146. View

4.
Lopez-Bermejo A, Botas-Cervero P, Ortega-Delgado F, Delgado E, Garcia-Gil M, Funahashi T . Association of ADIPOR2 with liver function tests in type 2 diabetic subjects. Obesity (Silver Spring). 2008; 16(10):2308-13. DOI: 10.1038/oby.2008.344. View

5.
Beulens J, van der A D, Grobbee D, Sluijs I, Spijkerman A, van der Schouw Y . Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care. 2010; 33(8):1699-705. PMC: 2909045. DOI: 10.2337/dc09-2302. View